Abstract
This chapter is about the technique of anti-VEGF injection. The needle and syringe, the volume of medication and anaesthesia are described. Then how to inject at the bedside and how to inject in the operation room with the microscope are explained in detail. A video is included.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Koçluk Y, Alyamaç Sukgen E. Intravitreal anti-VEGF treatment for retinopathy of prematurity in infants with active adenoviral keratoconjunctivitis. Cutan Ocul Toxicol. 2018;37:15–8.
Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ, Cunningham ET Jr, DʼAmico DJ, Dugel PU, Flynn HW Jr, Freund KB, Haller JA, Jumper JM, Liebmann JM, McCannel CA, Mieler WF, Ta CN, Williams GA. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 2014;34:S1–S18.
Laws DE, Haslett R, Ashby D, O’Brien C, Clark D. Axial length biometry in infants with retinopathy of prematurity. Eye (Lond). 1994;8:427–30.
Wright LM, Vrcek IM, Scribbick FW 3rd, Chang EY, Harper CA 3rd. Technique for infant intravitreal injection in treatment of retinopathy of prematurity. Retina. 2017;37:2188–90.
Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364:603–15.
Author information
Authors and Affiliations
1 Electronic Supplementary Material
Injection of Lucentis for ROP (WMV 9025 kb)
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Spandau, U., Kim, S.J. (2019). Technique of Anti-VEGF Injection. In: Pediatric Retinal Vascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-13701-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-13701-4_16
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-13700-7
Online ISBN: 978-3-030-13701-4
eBook Packages: MedicineMedicine (R0)